Search Results for keywords:"seizure disorders"

The Federal Motor Carrier Safety Administration (FMCSA) has decided to grant exemptions to three individuals with epilepsy or seizure disorders, allowing them to operate commercial motor vehicles across state lines. This decision, effective from January 11, 2021, until January 11, 2023, was based on each individual's medical history and stable treatment regimen. The individuals granted these exemptions have been seizure-free for many years while on medication. The FMCSA believes that this exemption ensures a safety level similar to, or better than, what the standard regulations would achieve.

The Federal Motor Carrier Safety Administration (FMCSA) has received applications from 11 individuals seeking an exemption from rules prohibiting people with epilepsy or seizure disorders from driving commercial motor vehicles in interstate commerce. These individuals are taking anti-seizure medication and have been seizure-free for varying periods, with support from their physicians for receiving an exemption. The agency is asking for public comments on these exemption requests by April 28, 2025. If approved, the exemptions would allow these applicants to legally operate commercial vehicles across state lines.

The Federal Motor Carrier Safety Administration (FMCSA) issued a correction to a previous notice about exemptions for 11 interstate commercial vehicle drivers with epilepsy or seizure disorders. Originally, the expiration date for these exemptions was listed as November 13, 2024, but this correction updates the date to November 13, 2026. These exemptions allow the affected drivers to continue operating commercial vehicles if they meet certain conditions, despite their medical history.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for ten individuals, allowing them to drive commercial motor vehicles even though they have epilepsy or seizure disorders, as long as they remain seizure-free and under stable treatment. These exemptions are valid for two years and enable the individuals, who are on anti-seizure medication, to continue working in interstate commerce. FMCSA ensures ongoing safety through annual medical reports and examinations, and while the exemption is in effect, states cannot enforce conflicting laws against these drivers. If any conditions are not met or if safety is compromised, the exemptions can be revoked.

The Federal Motor Carrier Safety Administration has received exemption requests from seven individuals who have epilepsy or related conditions. Normally, people with such medical conditions are prohibited from driving commercial vehicles interstate because of risks like seizures. However, these individuals have been seizure-free for many years and are taking or have stopped taking anti-seizure medication. If the exemptions are granted, these individuals would be allowed to drive commercial motor vehicles across state lines. The agency is asking for public comments on these requests by March 25, 2021.

The Federal Motor Carrier Safety Administration (FMCSA) has issued a notice to correct a spelling error in a previous notice regarding the renewal of exemptions for 19 interstate commercial motor vehicle (CMV) drivers who have epilepsy or seizure disorders. These exemptions allow the drivers to operate CMVs despite having a history of seizures, as long as they meet certain conditions. Originally published on January 6, 2025, the misspelled name "Kieth Maat (KS)" has been corrected to "Keith Maat (KS)." This correction became effective as of March 27, 2025.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for eight individuals, allowing them to continue driving commercial motor vehicles despite having epilepsy or a history of seizures. These individuals are taking medication for their condition, and FMCSA has determined that the exemptions provide a safety level equal to or greater than the standard regulations. The exemptions are valid for two years, and can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for seven drivers who have epilepsy or seizure disorders, allowing them to continue driving commercial motor vehicles across state lines. These exemptions, effective from August 31, 2024, to August 31, 2026, were granted after the FMCSA determined that they would maintain or exceed safety standards for drivers. Despite public invitations for comments, no feedback was received during the review periods. Each exemption will last two years unless revoked due to non-compliance, decreased safety, or inconsistency with regulatory goals.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for 10 individuals who have a history of epilepsy or seizures. Normally, drivers with such medical history are not allowed to operate commercial motor vehicles (CMVs) in interstate commerce due to safety regulations. However, these exemptions allow the individuals to continue driving as long as they are on anti-seizure medication, ensuring safety is equivalent to standard regulations. The exemptions are valid for two years from their effective date but can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation, is considering granting exemptions for 32 individuals who have a history of epilepsy or seizure disorders, allowing them to drive commercial motor vehicles across state lines. These individuals are currently taking medication and have been seizure-free for a significant period. FMCSA requests public comments on these exemption requests to ensure they meet safety requirements and provide an equivalent or higher level of safety than current regulations. The agency will review each applicant’s medical history and driving record before deciding.